RETINAL VASCULITIS OR VASCULAR OCCLUSION AFTER BROLUCIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A SYSTEMATIC REVIEW OF REAL-WORLD EVIDENCE.

Charles C Wykoff,Hidetaka Matsumoto,Mark R Barakat,Helene Karcher, Anthony Lozama,Andrew Mayhook, Olorunfemi A Oshagbemi, Olessia Zorina,Tarek S Hassan,Arshad M Khanani,Jeffrey S Heier

Retina (Philadelphia, Pa.)（2023）

引用 1|浏览22

暂无评分

摘要

Most RV/RO events reported after brolucizumab in early real-world practice occurred in women. Among eyes with VA measurements, approximately half experienced VA loss; overall, about one third had VA reduction of ≥0.30 logMAR at latest follow-up, with indications of regional variations.

查看译文

关键词

macular degeneration,brolucizumab,age-related

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要